ADAMTSL2 and colorectal carcinoma: Furthermore, we investigate the correlation between ADAMTSL2 and immune infiltration, immune checkpoint genes, tumor mutation burden (TMB), microsatellite instability (MSI), tumor stemness index (mRNAsi), and drug sensitivity in CRC.